The American Society for Radiation Oncology (ASTRO) has issued a new guideline on adjuvant radiotherapy in locally advanced non-small cell lung cancer (NSCLC).
The guideline's executive summary is published in the May-June issue of Practical Radiation Oncology. The complete guideline cites 35 years of data to help guide current treatment and future research and is available online as an open-access article in the journal.
The guideline covers the following:
- Ideal external-beam dose fractionation for curative-intent treatment of locally advanced NSCLC with radiotherapy alone without chemotherapy
- Ideal external-beam dose fractionation for curative-intent treatment of locally advanced NSCLC with chemotherapy
- Ideal timing of external-beam radiation therapy in relation to systemic chemotherapy for curative-intent treatment of locally advanced NSCLC
- Indications for adjuvant postoperative radiation therapy for curative-intent treatment of locally advanced NSCLC
- When neoadjuvant radiotherapy or chemoradiation prior to surgery is indicated for curative-intent treatment of locally advanced NSCLC
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
